BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37907644)

  • 1. Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer.
    Hu Q; Wang R; Zhang J; Xue Q; Ding B
    Cancer Immunol Immunother; 2023 Dec; 72(12):4293-4308. PubMed ID: 37907644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptome analysis reveals heterogeneity of neutrophils in non-small cell lung cancer.
    Wang Y; Zhu Z; Luo R; Chen W
    J Gene Med; 2024 May; 26(5):e3690. PubMed ID: 38735760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
    Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
    Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma.
    Chung JY; Tang PC; Chan MK; Xue VW; Huang XR; Ng CS; Zhang D; Leung KT; Wong CK; Lee TL; Lam EW; Nikolic-Paterson DJ; To KF; Lan HY; Tang PM
    Nat Commun; 2023 Mar; 14(1):1794. PubMed ID: 37002229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation.
    Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S
    Front Immunol; 2022; 13():974581. PubMed ID: 36159860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-cell-secreted CXCL11 promoted CD8
    Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y
    J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer.
    Shi J; Li J; Wang H; Li X; Wang Q; Zhao C; Cheng L; Han R; Chen P; Guo H; Tang Z; Zhou C; Zhang Z; Wu F
    Lung Cancer (Auckl); 2023; 14():85-99. PubMed ID: 38025400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
    Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
    Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
    Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
    Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
    Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy.
    Chen Y; Zhou X; Qiao J; Bao A
    Cell Physiol Biochem; 2017; 41(4):1370-1382. PubMed ID: 28427045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.
    Datar I; Sanmamed MF; Wang J; Henick BS; Choi J; Badri T; Dong W; Mani N; Toki M; Mejías LD; Lozano MD; Perez-Gracia JL; Velcheti V; Hellmann MD; Gainor JF; McEachern K; Jenkins D; Syrigos K; Politi K; Gettinger S; Rimm DL; Herbst RS; Melero I; Chen L; Schalper KA
    Clin Cancer Res; 2019 Aug; 25(15):4663-4673. PubMed ID: 31053602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
    Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
    Jiao P; Hou J; Yao M; Wu J; Ren G
    Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer.
    Zhang C; Tang B; Hu J; Fang X; Bian H; Han J; Hou C; Sun F
    Bioengineered; 2021 Dec; 12(1):8872-8884. PubMed ID: 34637697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.